ArticlePloS one2017

Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial.

Mandy Kader Konde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.